The RealReal (NASDAQ:REAL), an online luxury goods consignment store, raised $300 million by offering 15 million shares at $20 per share, $1 above the top end of its expected range. The San Francisco-based company sells women’s, men’s and kids’ clothing, jewelry and watches, homegoods and art. It offers a subscription program, which offers customers early access to its products.
The stock shot out of the gate, opening at $28 and ticking up to $28.41, 42% above its IPO price.
READ: IPO Roundup: BridgeBio Pharma surges, Change Healthcare slumps in busy day of health care IPOs
Karuna Therapeutics (NASDAQ:KRTX), a clinical-stage biopharmaceutical company based in Boston, offered 5.6 million shares at $16 per share, raising $89 million. The Boston-based company offered 1.2 million more shares than originally announced, and priced at the midpoint of its expected range. The company's lead drug candidate, KarXT, is currently part of a Phase 2 trial for the treatment of acute psychosis in patients with schizophrenia. Preliminary results are expected in late 2019.
Shares debuted at $18.50 and jumped to $23.36 Friday afternoon, 46% higher than the IPO price.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel